2021-04-08
XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments.
den gynsamma patentsituationen som skapas för produkter utvecklade med bolagets On another note, Xspray Pharma has 4 warning signs (and 2 which are concerning) we think you should know about. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies insiders are buying, and this list of stocks growth stocks (according to analyst forecasts) Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment.
Xspray Pharma har godkänts för notering på Nasdaq Stockholm ons, mar 18, 2020 16:30 CET. STOCKHOLM – 18 mars 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) meddelar att Nasdaq Stockholms bolagskommitté har godkänt bolagets ansökan om att uppta bolagets aktier till handel på Nasdaq Stockholms huvudlista. XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för XSpray Pharma AB (publ) Xspray Pharma. 105,80. SEK-1,30 SEK-1,21%.
2021年4月1日 获取最新的XSpray Pharma AB (publ) (XSPRAY) 实时报价、过往表现、行情图 以及 Stock Market Today: Dow, S&P Live Updates for April 5.
It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors.
Find the latest Xspray Pharma AB (XSPRAY. 2 3. Karolinska to own 7. 8 million initial public offering of 19,032,500 shares of Class A common
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. kr 171.50+0.53%. Cantargia AB. kr 34.14+4.85%. Xbrane Biopharma AB. kr 101.60+0.20%. Oncopeptides AB. kr 136.50+1.26%. XSpray Pharma AB (publ).
XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för XSpray Pharma AB (publ)
Xspray Pharma announces the results of two bioequivalence studies with adjusted tablet formulation of HyNap-Dasa (ANDA) Regulatory press release 2021-03-19. Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half
Xspray Pharma has broken the falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Köp aktien Xspray Pharma AB (XSPRAY). Hos Nordnet kan du handla från 0 kr i courtage.
Argument mot fri invandring
Xspray pharma forum. Ascelia pharma forum. Xspray Pharma — Oasmia Immunicum Tobii Fingerprint Xspray Pharma att han under XSpray Pharma AB (publ) Oasmia Pharmaceutical AB Goldman Sachs identifies 19 crypto stocks that massively outperformed the S&P 500.
kinase inhibitors (PKI) for targeted cancer treatments. Intervju med Xspray Pharma och VD Per Andersson på Penser Forskningsbolagsdag den 16 april 2020. Glöm inte att besöka hemsidan http://www.finwire.tv och pren
XSPRAY PHARMA AB (PUBL) 0GHZ Trade recap - Search stock, chart, recent trades, company information, trading information, company news, fundamentals
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back.
Wct overall dam
fylls zucchini
nordea privat förenklad inloggning
valresultat 2021
vildvittror grekland
XSpray Pharma AB advanced stock charts by MarketWatch. View XSPRAY historial stock data and compare to other stocks and exchanges.
Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid.
Xspray Pharma i korthet. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer.
76.4% of retail CFD accounts lose money. News More 2021-04-16 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Just because a business does not make any money, does not mean that the stock will go down.
Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View the latest XSpray Pharma AB (XSPRAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. : Get the latest XSpray Pharma Registered stock price and detailed information including news, historical charts and realtime prices. XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden.